CoChat

Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy

Marchezan, Josemar, Winkler dos Santos, Eduardo Geyer Arrussul, Deckmann, Iohanna, Riesgo, Rudimar dos Santos · 2018 · Neuroimmunomodulation

The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.

Abstract

Autism spectrum disorder (ASD) is a complex neurodevelopmental disorder with an unknown etiology and currently few effective therapies. Immune system alterations have being demonstrated in ASD, both in humans and via animal models; immune imbalance thus arises as a possible pathway for drug intervention. In this review, the studies were classified into 2 major groups: (1) clinical research whose authors classify therapies with primary anti-inflammatory and immunomodulatory actions, making use of: sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, flavonoid luteolin, corticosteroids, oral immunoglobulin, intravenous immunoglobulin, cell therapy, dialyzable lymphocyte extracts, minocycline, and pioglitazone; and (2) other ASD therapies already used or currently under study whose initial characteristics were neither anti-inflammatory nor immunomodulatory initially, but displayed a capacity for immunomodulation throughout the treatment: risperidone, vitamin D, omega-3, Ginkgo biloba, L-carnosine, N-acetylcysteine, and microbiome restoration. These studies used various data acquisition methodologies. Questions arose such the need for randomized and placebo-controlled studies with greater numbers of participants as well as the use of biomarkers to refine the treatment of autistic subjects.

Overview

Integrity signals

Registry

Crossref · 10.1159/000492225

Cites

236 of 236 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

1 retracted

Show all 236 references

Cited by

See all 74

Metadata

Authors
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S.
Affiliations
Universidade Federal do Rio Grande do Sul (BR)
Venue
Neuroimmunomodulation
Publisher
S. Karger AG
Published
2018
Volume
25
Issue
5-6
Pages
300-319
ISSN
  • 1021-7401 (ISSN-L)
  • 1423-0216
OpenAlex
W2892087768
Cited by
70
References
236
Citations by year
2026: 3 · 2025: 4 · 2024: 9 · 2023: 10 · 2022: 10 · 2021: 14 · 2020: 13 · 2019: 4 · 2018: 3
FWCI
5.05
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • NeuroImmunoModulation (publishedVersion)
  • PubMed (publishedVersion)
Funders
Centers for Disease Control and Prevention
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Health Sciences › Medicine › Psychiatry and Mental health › Child Nutrition and Feeding Issues
Keywords
autism spectrum disorder, immune dysfunction, immunomodulatory therapy, anti-inflammatory therapy, sulforaphane, celecoxib, lenalidomide, pentoxifylline, spironolactone, luteolin, corticosteroids, intravenous immunoglobulin, oral immunoglobulin, cell therapy, minocycline, pioglitazone, risperidone, vitamin D, omega-3 fatty acids, Ginkgo biloba, L-carnosine, N-acetylcysteine, microbiota restoration, biomarkers
MeSH terms
Autism Spectrum Disorder, Animals, Humans, Immunotherapy, Neuroimmunomodulation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy. https://app.cochat.ai/papers/10.1159/000492225
The paper
Marchezan, J., Winkler dos Santos, E. G. A., Deckmann, I., & Riesgo, R. D. S. (2018). Immunological Dysfunction in Autism Spectrum Disorder: A Potential Target for Therapy. Neuroimmunomodulation. https://doi.org/10.1159/000492225

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.